- Investing Ideas
- /
- Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
13
Companies with a Value score of at least 3, ordered by Value score
13 companies
Merck
Market Cap: CL$230.5b
Operates as a healthcare company worldwide.
MRKCL
CL$76,219.00
7D
0%
1Y
-23.4%
Amgen
Market Cap: CL$184.0b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGNCL
CL$293,440.00
7D
0%
1Y
-4.0%
Pfizer
Market Cap: US$142.6b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$26.06
7D
0%
1Y
-6.8%
Merck
Market Cap: US$230.5b
Operates as a healthcare company worldwide.
MRK
US$79.14
7D
0%
1Y
-38.6%
Johnson & Johnson
Market Cap: CL$480.8b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJCL
CL$169,500.00
7D
0%
1Y
10.1%
Johnson & Johnson
Market Cap: US$480.8b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$191.05
7D
0%
1Y
28.9%
Gilead Sciences
Market Cap: CL$154.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDCL
CL$79,000.00
7D
0%
1Y
0%
Biogen
Market Cap: CL$24.2b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIBCL
CL$140,900.00
7D
0%
1Y
-46.0%
Pfizer
Market Cap: CL$142.6b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFECL
CL$23,200.00
7D
0%
1Y
-17.4%
Biogen
Market Cap: US$24.2b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$130.24
7D
0%
1Y
-46.8%
Amgen
Market Cap: US$184.0b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$255.16
7D
0%
1Y
0%
Gilead Sciences
Market Cap: US$154.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$110.43
7D
0%
1Y
23.1%
AbbVie
Market Cap: CL$413.6b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBVCL
CL$171,590.00
7D
0%
1Y
-5.0%